Oral and Oropharyngeal Cancer

The prevalence of Oral and Oropharyngeal Cancer continues to rise worldwide, related to the increase in consumption of tobacco, alcohol and other carcinogenic products. However, there has also been a significant reduction in mortality due to increasing awareness, early diagnosis and advances in treatments. This second edition of a bestseller reviews every aspect of the diagnosis and treatment of the orofacial cancer patient. As with the first edition, the book is organized in three parts, covering Pathology and Biology, Clinical Management, and Outcomes and Follow-up.

Table of Contents

Part I: Pathology and Biology. Global epidemiology. Etiology and risk factors. Clinical features and diagnosis. Histopathology. Molecular pathology. Part II Clinical Management. Clinical evaluation and differential diagnosis. Workup and Staging. Factors affecting choice of treatment. Management of potentially malignant disorders of the mouth and oropharynx. Cervical lymph nodes. Surgical approached to oral cavity and oropharynx. Radiotherapy. Chemotherapy. Complications of treatment and their management. Reconstructive Surgery: Soft tissue. Reconstructive Surgery: Mandible. Reconstructive Surgery: Maxilla. Palliative care for head and neck cancer. Part III Outcomes and Follow-up. Oncologic Outcomes. Functional　outcomes and rehabilitation. Prognostic Nomograms. Prosthetic restoration and rehabilitation. Prevention.

Jatin P. Shah, MD,MS(Surg),PhD(Hon),DSc(Hon),FACS,FRCS(Hon),FDSRCS(hon),FRCSDS(Hon),FRCSI(Hon),FRACS(Hon), Professor of Surgery, E W Strong Chair in Head and Neck Oncology, Memorial Sloan Kettering Cancer Center, New York, USA

Newell Johnson  CMG, FMedSci, Emeritus Professor. Honorary Professor of Dental Research, Menzies Health Institute Queensland and School of Dentistry and Oral Health, Griffith University. Emeritus Professor, Griffith Institute for Educational Research, Australia. Emeritus Professor of Oral Health Sciences, King's College London, UK